Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)

Status Completed

Clinical Trial Summary

The purpose of this study is to determine if revaccination with pneumococcal vaccine (PNEUMOVAX™ 23, V110) is well tolerated and produces an immune response in older Japanese adults. The primary hypothesis being tested is that the geometric mean concentration of antibodies to pneumococcal polysaccharide serotypes 3, 6B, and 23F at 4 weeks after revaccination will be superior to that before revaccination in Japanese adults who received a primary vaccination at least 5 years before revaccination.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02260882
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 4
Start date	October 31, 2014
Completion date	April 9, 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02463539` - Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis	N/A
Completed	`NCT03095326` - Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia	Phase 4
Completed	`NCT02572635` - A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax	Phase 1
Completed	`NCT01654263` - A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine	Phase 2
Completed	`NCT01531322` - A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects	Phase 1
Completed	`NCT00496093` - Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)	Phase 3
Completed	`NCT02062281` - Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults	Phase 4
Completed	`NCT00133549` - 9-valent CRM 197 Pneumococcal	Phase 2
Completed	`NCT03467984` - A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants	Phase 2
Active, not recruiting	`NCT03489018` - The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants	Phase 4
Recruiting	`NCT02463578` - Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis	N/A
Completed	`NCT00535730` - ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)	Phase 3
Completed	`NCT02558751` - Pneumonia Vaccine in Aging HIV Positive Individuals	Phase 0
Completed	`NCT02515240` - Immune Response to Pneumococcal Vaccination in HIV Infected Individuals	Phase 0
Completed	`NCT00560950` - Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)	Phase 3
Completed	`NCT05425732` - Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)	Phase 3
Not yet recruiting	`NCT03549208` - A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults	Phase 1
Completed	`NCT03619252` - Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents	Phase 4
Not yet recruiting	`NCT03341195` - Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan	N/A
Recruiting	`NCT06177912` - A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)	Phase 3